It is too early to know whether the prompt response to the virus is enough to turn the tide
International collaboration plotted 149 metres of biological wiring in fruit fly
Artificial intelligence used to help researchers plan experiments and better predict outcomes
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
The next stage in the war on cancer may be enlisting patients’ own blood cells to fight the disease
The reduced effectiveness of antibiotics risks severe disruption to the global economy
Results offer hope of progress in combating bladder tumours and some forms of breast cancer
Rita Charon believes that letting patients tell their own stories is the best way to fix a broken system
More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts
Flying blind is dangerous. Technology can build on the basics of local and national data collection
Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks
CDC officials recount the critical role of politicians and others surrounding the story of HIV
Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation
UCL unveils new sensory device that will help doctors to spot disease early and advance robotic surgery
Scientists’ goal is not to resurrect vanished creatures but discover whether ancient molecules can solve modern problems
A three-part FT series looks at how an influx of money is changing prospects for patients but creating new challenges for healthcare systems
Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology
More trials urged as part of effort to slow cognitive declines with existing medicines
Wealthy world must help Africa prevent a potential regional health catastrophe
Nice’s ruling on lecanemab demonstrates the lack of readiness to roll out new treatments in the UK
The first in an FT series looking at the new energy behind the fight for cancer cures
Infectious disease professor Dimie Ogoina says cases are probably being under-reported
Third of patients wait longer than 62-day standard to start treatment, according to ONS data
WHO reviews Niger trial as issue highlights dilemma over threat of ‘superbugs’
Computer interface technology promises a ‘smart pacemaker’ to help sufferers of the motor disease
